Skip to main content
. 2019 Jul 2;29(5):675–692. doi: 10.1111/bpa.12748

Figure 6.

Figure 6

Distribution of Nav1.6 during de‐ and remyelination. Nodes of Ranvier in controls (no cuprizone treatment), 5 weeks cuprizone, 5 weeks cuprizone followed by 1 week of remyelination and 5 weeks cuprizone followed by 5 weeks of remyelination groups were visualized by staining for Nav1.6 followed by Alexa 633 labeled secondary antibody (shown in red). Scale bar represents 20 μm. Quantification of nodes is shown in (e).